USD 40.95
(-1.09%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | 4.17 Billion ZAR | 15.15% |
2023 | 3.62 Billion ZAR | -0.75% |
2022 | 3.65 Billion ZAR | 26.01% |
2021 | 2.89 Billion ZAR | 4.7% |
2020 | 2.76 Billion ZAR | 19.19% |
2019 | 2.32 Billion ZAR | 13.7% |
2018 | 2.04 Billion ZAR | 12.58% |
2017 | 1.81 Billion ZAR | 15.39% |
2016 | 1.57 Billion ZAR | 12.58% |
2015 | 1.39 Billion ZAR | 14.65% |
2014 | 1.21 Billion ZAR | 10.31% |
2013 | 1.1 Billion ZAR | 9.15% |
2012 | 1.01 Billion ZAR | 7.86% |
2011 | 937.59 Million ZAR | 13.89% |
2010 | 823.27 Million ZAR | 16.09% |
2009 | 709.17 Million ZAR | 19.76% |
2008 | 592.16 Million ZAR | 22.31% |
2007 | 484.15 Million ZAR | 46.66% |
2006 | 330.12 Million ZAR | 12.91% |
2005 | 292.38 Million ZAR | 373.78% |
2004 | 61.71 Million ZAR | -83.84% |
2003 | 382 Million ZAR | 19.92% |
2002 | 318.56 Million ZAR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q4 | 125.02 Million USD | 0.0% |
2024 Q2 | 98.87 Million USD | 0.0% |
2023 FY | 3.62 Billion ZAR | -0.75% |
2023 Q4 | 106.84 Million USD | 0.0% |
2023 Q2 | 93.42 Million USD | 0.0% |
2022 FY | 3.65 Billion ZAR | 26.01% |
2022 Q4 | 133.17 Million USD | 0.0% |
2022 Q2 | 100.53 Million USD | 0.0% |
2021 Q4 | 105.95 Million USD | 0.0% |
2021 Q2 | 87.54 Million USD | 0.0% |
2021 FY | 2.89 Billion ZAR | 4.7% |
2020 Q4 | 87.39 Million USD | 0.0% |
2020 Q2 | 84.55 Million USD | 0.0% |
2020 FY | 2.76 Billion ZAR | 19.19% |
2019 FY | 2.32 Billion ZAR | 13.7% |
2019 Q4 | 88.39 Million USD | 0.0% |
2018 FY | 2.04 Billion ZAR | 12.58% |
2017 FY | 1.81 Billion ZAR | 15.39% |
2016 FY | 1.57 Billion ZAR | 12.58% |
2015 FY | 1.39 Billion ZAR | 14.65% |
2014 FY | 1.21 Billion ZAR | 10.31% |
2013 FY | 1.1 Billion ZAR | 9.15% |
2012 FY | 1.01 Billion ZAR | 7.86% |
2011 FY | 937.59 Million ZAR | 13.89% |
2010 FY | 823.27 Million ZAR | 16.09% |
2009 FY | 709.17 Million ZAR | 19.76% |
2008 FY | 592.16 Million ZAR | 22.31% |
2007 FY | 484.15 Million ZAR | 46.66% |
2006 FY | 330.12 Million ZAR | 12.91% |
2005 FY | 292.38 Million ZAR | 373.78% |
2004 FY | 61.71 Million ZAR | -83.84% |
2003 FY | 382 Million ZAR | 19.92% |
2002 FY | 318.56 Million ZAR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Alternative Energy Partners, Inc. | -261.11 USD | 1597737452.074% |
Allstar Health Brands, Inc. | -215.75 Thousand USD | 1933750.985% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 624.14 Million USD | -568.406% |
Café Serendipity Holdings, Inc. | -1.43 Million USD | 290802.351% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | -47.57 Thousand USD | 8770022.22% |
HealthWarehouse.com, Inc. | -1.62 Million USD | 257354.945% |
LIGAND PHARMACEUTICAL INC | 9.82 Million USD | -42378.892% |
MedGen, Inc. | -15.54 USD | 26845894565.894% |
Omni Health, Inc. | 405.52 Thousand USD | -1028666.029% |
Oxford Investments Holdings Inc. | -342.3 Thousand USD | 1218859.987% |
Pineapple, Inc. | -1.47 Million USD | 282432.861% |
ScripsAmerica, Inc. | -3.8 Million USD | 109674.964% |